Skip to main content
NUWE
NASDAQ Industrial Applications And Services

Two Directors Resign from Nuwellis Board Citing Governance Failures, Lack of Transparency, and Dilutive Transactions

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.05
Mkt Cap
$2.426M
52W Low
$0.96
52W High
$45.419
52W Position info
9.4% above low
Off High info
98% below high
Rel. Volume
Market data snapshot near publication time

NUWE is trading near its 52-week low of $0.96 (9.4% above the low).

Summary

Two independent directors, Mika Grasso and Katharyn Field, resigned from Nuwellis's Board of Directors, citing severe disagreements over corporate governance, lack of transparency, exclusion from material decisions, and alleged misconduct by management.


Key Events · Executive and Board Changes · NUWE

  • Contentious Director Resignations

    Mika Grasso and Katharyn Field resigned from the Board of Directors, effective March 26, 2026, citing serious disagreements with the Company.

  • Allegations of Governance Failures

    Resignation letters detail alleged failures to provide information, exclusion from material decisions (including a 'highly dilutive transaction' and the Rendiatech acquisition), ignored litigation risks, and defamation by the CEO.

  • Management Disagreement

    The Company explicitly disagrees with the directors' allegations, stating they contain 'numerous errors of fact, misleading speculations and malicious interpretations.'

  • Board Size Reduction

    Following the resignations, the Board determined to decrease its size from seven to five members, effective immediately.


Analysis · NUWE · Industrial Applications And Services

The resignations of two independent directors, accompanied by highly critical letters detailing alleged governance failures, are a significant negative development for Nuwellis. The allegations include exclusion from decisions on a "highly dilutive transaction" and the Rendiatech acquisition, denial of information, ignored litigation risks, and even defamation by the CEO. These issues are particularly concerning given the company's existing "going concern" warning, material weaknesses in internal controls, and Nasdaq delisting threat disclosed in its recent 10-K. The detailed accusations from independent directors suggest deep-seated problems within the company's leadership and oversight, which could further erode investor confidence and potentially invite regulatory scrutiny or shareholder action. The reduction in board size from seven to five members following these resignations also concentrates power, raising further governance concerns.

At the time of this filing, NUWE was trading at $1.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $0.96 to $45.42. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NUWE - Latest Insights

NUWE
Jul 27, 2026, 8:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.99
Real-time Price: $1.88 info
Change: -$0.110 (-6%) info
Market Cap: $703.089K info
NUWE
Jul 24, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.01
Real-time Price: $1.88 info
Change: -$0.1254 (-6%) info
Market Cap: $703.089K info
NUWE
Jul 07, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $3.15
Real-time Price: $1.88 info
Change: -$1.27 (-40%) info
Market Cap: $703.089K info
NUWE
Jun 26, 2026, 5:11 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $4.02
Real-time Price: $1.88 info
Change: Reverse Stock Split info
Market Cap: $703.089K info
NUWE
Jun 24, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.0851
Real-time Price: $1.88 info
Change: Reverse Stock Split info
Market Cap: $703.089K info